Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 109

Similar articles for PubMed (Select 24669233)

1.

Pleural fluid prealbumin and C-reactive protein in the differential diagnosis of infectious and malignant pleural effusions.

Ji Q, Huang B, Wang M, Ren Z, Zhang S, Zhang Y, Sheng L, Yu Y, Jiang J, Chen D, Ying J, Yu J, Qiu L, Wan R, Li W.

Exp Ther Med. 2014 Apr;7(4):778-784. Epub 2014 Jan 27.

2.

Pleural fluid C-reactive protein contributes to the diagnosis and assessment of severity of parapneumonic effusions.

Porcel JM, Bielsa S, Esquerda A, Ruiz-González A, Falguera M.

Eur J Intern Med. 2012 Jul;23(5):447-50. doi: 10.1016/j.ejim.2012.03.002. Epub 2012 Mar 23.

PMID:
22726374
3.

A simple C-reactive protein measurement for the differentiation between tuberculous and malignant pleural effusion.

Chierakul N, Kanitsap A, Chaiprasert A, Viriyataveekul R.

Respirology. 2004 Mar;9(1):66-9.

PMID:
14982604
4.

Use of pleural fluid C-reactive protein in diagnosis of pleural effusions.

Yilmaz Turay U, Yildirim Z, Türköz Y, Biber C, Erdoğan Y, Keyf AI, Uğurman F, Ayaz A, Ergün P, Harputluoğlu M.

Respir Med. 2000 May;94(5):432-5.

PMID:
10868705
5.

Pleural fluid pentraxin-3 for the differential diagnosis of pleural effusions.

Yeo CD, Kim JW, Cho MR, Kang JY, Kim SJ, Kim YK, Lee SH, Park CK, Kim SH, Park MS, Yim HW, Park JY.

Tuberc Respir Dis (Seoul). 2013 Dec;75(6):244-9. doi: 10.4046/trd.2013.75.6.244. Epub 2013 Dec 24.

6.

Diagnostic value and prognostic significance of pleural C-reactive protein in lung cancer patients with malignant pleural effusions.

Park DS, Kim D, Hwang KE, Hwang YR, Park C, Seol CH, Cho KH, Kim BR, Park SH, Jeong ET, Kim HR.

Yonsei Med J. 2013 Mar 1;54(2):396-402. doi: 10.3349/ymj.2013.54.2.396.

7.

Diagnostic and prognostic significance of survivin levels in malignant pleural effusion.

Görgün D, Seçik F, Midilli K, Akkaya V, Yıldız P.

Respir Med. 2013 Aug;107(8):1260-5. doi: 10.1016/j.rmed.2013.04.011. Epub 2013 Jun 18.

PMID:
23791464
9.

Pleural fluid interleukin-8 and C-reactive protein for discriminating complicated non-purulent from uncomplicated parapneumonic effusions.

Porcel JM, Galindo C, Esquerda A, Trujillano J, Ruiz-González A, Falguera M, Vives M.

Respirology. 2008 Jan;13(1):58-62. doi: 10.1111/j.1440-1843.2007.01189.x.

PMID:
18197912
10.

Use of pleural fluid C-reactive protein in laboratory diagnosis of pleural effusions.

Castaño Vidriales JL, Amores Antequera C.

Eur J Med. 1992 Jul-Aug;1(4):201-7.

PMID:
1341445
11.

Diagnostic accuracy of pleural fluid polymorphonuclear elastase in the differentiation between pyogenic bacterial infectious and non-infectious pleural effusions.

Alegre J, Suriñach JM, Varela E, Armadans L, Marti R, Segura R, Aleman C, Falcó V, Fernandez de Sevilla T.

Respiration. 2000;67(4):426-32.

12.

Pleural fluid myeloperoxidase as a marker of infectious pleural effusions.

Alegre J, Jufresa J, Alemán C, Segura R, Armadans L, Marti R, Cervera C, Fernández de Sevilla T.

Eur J Intern Med. 2001 Jul;12(4):357-362.

PMID:
11395299
13.

Acute phase markers for the differentiation of infectious and malignant pleural effusions.

Kiropoulos TS, Kostikas K, Oikonomidi S, Tsilioni I, Nikoulis D, Germenis A, Gourgoulianis KI.

Respir Med. 2007 May;101(5):910-8. Epub 2007 Jan 31.

14.

The diagnostic value of apolipoprotein E in malignant pleural effusion associated with non-small cell lung cancer.

Wang Y, Chen Z, Chen J, Pan J, Zhang W, Pan Q, Ding H, Lin X, Wen X, Li Y, Meng QH.

Clin Chim Acta. 2013 Jun 5;421:230-5. doi: 10.1016/j.cca.2013.03.013. Epub 2013 Mar 21.

PMID:
23523589
15.

[Level of soluble programmed death ligand 1 in pleural effusion and peripheral blood of patients with tuberculous pleural effusion and its clinical implications].

Pan X, Xing Y, Shi M, Zhou T, Qian B, Chen Y.

Zhonghua Yi Xue Za Zhi. 2014 May 27;94(20):1543-6. Chinese.

PMID:
25146741
16.

Predictive role of adenosine deaminase for differential diagnosis of tuberculosis and malignant pleural effusion in Turkey.

Yildiz PB, Yazar EE, Gorgun D, Secik F, Cakir G.

Asian Pac J Cancer Prev. 2011;12(2):419-23.

17.

Diagnostic and prognostic significance of lysophosphatidic acid in malignant pleural effusions.

Bai CQ, Yao YW, Liu CH, Zhang H, Xu XB, Zeng JL, Liang WJ, Yang W, Song Y.

J Thorac Dis. 2014 May;6(5):483-90. doi: 10.3978/j.issn.2072-1439.2014.02.14.

18.

Diagnostic value of superoxide dismutase in tuberculous and malignant pleural effusions.

Wang XF, Wu YH, Jiao J, Guan CP, Yang XG, Wang MS.

Asian Pac J Cancer Prev. 2013;14(2):821-4.

19.

Discrimination of exudative pleural effusions based on multiple biological parameters.

Daniil ZD, Zintzaras E, Kiropoulos T, Papaioannou AI, Koutsokera A, Kastanis A, Gourgoulianis KI.

Eur Respir J. 2007 Nov;30(5):957-64. Epub 2007 Aug 9.

20.

Biomarkers of infection for the differential diagnosis of pleural effusions.

Porcel JM, Vives M, Cao G, Bielsa S, Ruiz-González A, Martínez-Iribarren A, Esquerda A.

Eur Respir J. 2009 Dec;34(6):1383-9. doi: 10.1183/09031936.00197208. Epub 2009 Jun 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk